- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02727257
The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients
Study Overview
Detailed Description
Objective: To evaluate the attentive performances in Parkinsonians in comparison with healthy controls and the effect of motor-cognitive rehabilitation program on attention.
Methods: 103 Parkinsonians (stage 2,5-3 H&Y) hospitalized for a 4-week Multidisciplinary Intensive Rehabilitation Treatment and 34 healthy controls were enrolled. All subjects underwent three different attentive tasks: visual reaction times, auditory reaction times and multiple choices reaction times tasks. To evaluate the effect of rehabilitation on attention, patients performed the same battery at discharge. To investigate the effects of MIRT on motor functions and quality of life we also assessed UPDRS III, Timed Up and Go test and Parkinson's Disease Questionnaire.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Como
-
Gravedona ed Uniti, Como, Italy, 22015
- Department of Parkinson's Disease and Brain Injury Rehabilitation, of the 'Moriggia-Pelascini' Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- stage 2.5-3 according to the Hoehn & Yahr scale
- pharmacological treatment for the last 8 weeks and during the hospitalization
- Mini Mental State Examination (MMSE) ≥ 24
Exclusion Criteria:
- any focal brain lesion detected in brain imaging studies (Computed Tomography or Magnetic Resonance Imaging) performed in the previous twelve months
- disabling drug-induced dyskinesias
- disturbing resting and/or action tremor, corresponding to scores 2 to 4 in the specific items of Unified Parkinson's Disease Rating Scale section 3 (UPDRS III)
- behavioral disturbances (evaluated with Neuropsychiatric Inventory)
- visual and auditory dysfunctions according to the general clinical evaluation and medical history
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MIRT
MIRT consists of a 4-week physical therapy that entails four daily sessions, five days a week, in a hospital setting.
The first session comprise cardiovascular warm-up activities, relaxation, muscle-stretching, exercises to improve the range of motion of spinal, pelvic and scapular joints, exercises to improve the functionality of the abdominal muscles, and postural changes in the supine position.
The second session includes aerobic exercises to improve balance and gait using a stabilometric platform, treadmill plus, crossover and cycloergometer.
All the exercises are aerobic.
The third is a session of occupational therapy to improve autonomy in day living activities.
The last session includes one hour of speech therapy.
|
MIRT consists of a 4-week physical therapy that entails four daily sessions, five days a week, in a hospital setting.
The duration of each session, including recovery periods, is about one hour.
The first session comprise cardiovascular warm-up activities, relaxation, muscle-stretching, exercises to improve the range of motion of spinal, pelvic and scapular joints, exercises to improve the functionality of the abdominal muscles, and postural changes in the supine position.
The second session includes aerobic exercises to improve balance and gait using a stabilometric platform, treadmill plus, crossover and cycloergometer.
The third is a session of occupational therapy to improve autonomy in day living activities.
The last session includes one hour of speech therapy.
|
|
No Intervention: healthy controls
we assessed the attentive Reaction Times in healthy controls, that don't receive rehabilitative treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multiple Choice Reaction Time task
Time Frame: 4 weeks
|
The task consisted of 40 trials.
The target was a number (1, 2, 3) whose presentation, on the centre of the screen, was randomized.
Each number was associated to a different response buttons .
In each single trial subjects had to press as quickly as possible the response button associated with the number that appeared on the screen.
We evaluated the accuracy of response and recorded the time between the appearance of target and the subject's response.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Simple Choice Reaction Time task
Time Frame: 4 weeks
|
The task consisted of 40 trials.
In each single trial, the subjects had to press the response button as quickly as possible when a red circle appeared on the screen.
The appearance of targets was mixed to a variable number of distractors consisting in single green circles.
Targets and distractors could appear in different positions of the screen at irregular intervals (1-3 seconds).
Distractors remained on the screen for 500 ms, while the target disappeared with the subject's response.
We evaluated the accuracy of response and recorded the time between the appearance of target and the subject's response.
|
4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Auditory Reaction Time task
Time Frame: 4 weeks
|
The task consisted of 40 trials.
In each single trial the subjects had to press a response button as quickly as possible at the presentation of the target that consisted of an acoustic stimulus (intensity of 94 dbA) presented at irregular intervals (1-3 seconds).
The stimulus ended after the subject's response.
The times between the presentation of the target and the subject's response were recorded.
|
4 weeks
|
|
Visual Reaction Time task
Time Frame: 4 weeks
|
The task consisted of 40 trials.
In each single trial, the subjects had to press a response button as quickly as possible at the appearance of the target that disappeared after the subject's response.
Target was a red circle that appeared on the centre of screen at irregular intervals (1-3 seconds).
The times between the appearance of the target and the subject's response were recorded.
|
4 weeks
|
|
Unified Parkinson's disease Rating Scale
Time Frame: 4 weeks
|
4 weeks
|
|
|
Parkinson Disease Questionnaire - 39
Time Frame: 4 weeks
|
4 weeks
|
|
|
Timed Up and Go Test
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rehabilitation and RT in PD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Mission TherapeuticsMichael J. Fox Foundation for Parkinson's Research; Parkinson's UKRecruitingParkinson's Disease (PD) | Early Stage Parkinson's Disease | Mild to Moderate Parkinson's DiseaseUnited Kingdom
Clinical Trials on MIRT
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease | Gait Disorders, Neurologic | Gait Disorder, SensorimotorItaly
-
Ospedale Generale Di Zona Moriggia-PelasciniCompleted
-
Ospedale Generale Di Zona Moriggia-PelasciniUnknownRehabilitation | PD | Gait Dysfunction, NeurologicItaly
-
Ospedale Generale Di Zona Moriggia-PelasciniUnknownParkinson DiseaseItaly
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson's DiseaseItaly
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedProgressive Supranuclear PalsyItaly
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease | Rehabilitation | Dexterity
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease and Pisa SyndromeItaly
-
Ospedale Generale Di Zona Moriggia-PelasciniCompleted
-
Ospedale Generale Di Zona Moriggia-PelasciniCompleted